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During pancreas development, endocrine precursors
and their progeny differentiate, migrate, and cluster to
form nascent islets. The transcription factor Neurogenin 3
(Neurog3) is required for islet development in mice, but
its role in these dynamic morphogenetic steps has been
inferred from fixed tissues. Moreover, little is known
about the molecular genetic functions of NEUROG3 in
human islet development. We developed methods for
gene transduction by viral microinjection in the epithe-
lium of cultured Neurog3-null mutant fetal pancreas,
permitting genetic complementation in a developmen-
tally relevant context. In addition, we developed meth-
ods for quantitative assessment of live-cell phenotypes
in single developing islet cells. Delivery of wild-type
NEUROG3 rescued islet differentiation, morphogenesis,
and live cell deformation, whereas the patient-derived
NEUROG3R107S allele partially restored indicators of
islet development. NEUROG3P39X, a previously unre-
ported patient allele, failed to restore islet differentia-
tion or morphogenesis and was indistinguishable from
negative controls, suggesting that it is a null mutation.
Our systems also permitted genetic suppression anal-
ysis and revealed that targets of NEUROG3, including
NEUROD1 and RFX6, can partially restore islet devel-
opment in Neurog3-null mutant mouse pancreata.
Thus, advances described here permitted unprece-
dented assessment of gene functions in regulating
crucial dynamic aspects of islet development in the
fetal pancreas.
Development of solid organs is a dynamic process, but
classical investigations of mammalian organogenesis have
been limited largely to static analysis of fixed tissues. In
the pancreas, epithelial cells form branched tubes that
develop into exocrine acinar and ductal cells required for
digestion. From that branching epithelium, endocrine
progenitors differentiate and initiate cell shape changes
culminating in delamination and outward migration into
overlying mesenchyme. Subsequently, migrating endo-
crine cells differentiate into hormone-producing cells,
including insulin+ and glucagon+ cells, that cluster to
form morphologically distinct, vital structures called the
islets of Langerhans, which regulate metabolism (1–3).
Methods to visualize single cells developing along this
endocrine lineage would advance our understanding of
islet development.
Pancreatic endocrine precursor development is regu-
lated by the basic helix-loop-helix transcription factor
Neurogenin3 (Neurog3). Mice without Neurog3 form
a pancreas but have no islet cells, other than a small
transient population of glucagon+ cells (4), and die peri-
natally with severe hyperglycemia and no detectable in-
sulin production (5). Mice ectopically expressing Neurog3
in early pancreatic progenitors divert cells toward an
endocrine fate (5–7). These and other findings indicate
that Neurog3 is both necessary and sufficient for induc-
ing pancreatic endocrine differentiation and establish-
ing islet cell fate during mouse development (8–13).
Humans with mutations in NEUROG3 suffer from con-
genital diarrhea, caused by a deficit of intestinal endo-
crine cells, that is accompanied by a varying severity of
insulin deficiency and diabetes (14–16). A subset of pa-
tient-derived NEUROG3 alleles may be hypomorphic or
null, based on assays in cell lines and nonmammalian
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systems (17). Puzzlingly, some patients with intestinal
anendocrinosis and neonatal diabetes harboring sus-
pected null NEUROG3 alleles have low but detectable
serum C-peptide, an indicator of insulin secretion, sug-
gesting that NEUROG3-independent b-cell development
may occur in humans (14,15). Thus, developmentally
relevant systems for testing gene function of human
alleles of NEUROG3 are needed. In mice, Neurog3 di-
rectly induces the expression of multiple targets, includ-
ing genes encoding the transcription factors, NeuroD1,
Pax4, Insm1, and Rfx6 (18–23). Mouse mutants lacking
each of those factors have distinct endocrine defects,
suggesting that gene networks governed by Neurog3
have multiple distinct phenotypic outputs (24,25).
Thus, simple methods for assessing the cellular and mo-
lecular functions of Neurog3 and its targets in the devel-
oping pancreas could prove useful for decoding regulatory
networks governing islet development.
During islet formation, studies of fixed tissues have
provided evidence that Neurog3 is required for initiation
of islet formation, which includes epithelial cell defor-
mation, delamination, outward movement, hormone ex-
pression, and clustering into polyclonal multicellular
aggregates. However, control of these transient features
of islet development by Neurog3 remains unclear, re-
flecting a lack of assays to quantify transient cellular
phenotypes. Prior studies show that Neurog3+ cells
lose polarized expression of markers including Mucin
and aPKC; express Snail2, a transcriptional regulator of
the epithelial-to-mesenchymal transition; and appear to
exit the fetal pancreatic epithelium (9,26). Hormone-
expressing progeny derived from Neurog3+ endocrine
progenitor cells are detected in fixed tissues both as sin-
gle cells and as small clusters of multiple islet cells
throughout development. As development progresses,
these islet clusters enlarge and remodel to form mature
islet morphology (27–30). Overexpression of Neurog3 in
an immortalized pancreatic ductal cell line altered ex-
pression of a subset of genes involved in cell migration
and intercellular interactions, suggesting a role for Neu-
rog3 in initiating transcriptional changes that promote
migratory phenotypes (31). Prior important live-cell
analysis in the developing mouse pancreas (32) permit-
ted description on a multicellular scale of fetal epithelial
branching and b-cell movement but did not image sin-
gle cells from multiple cell populations simultaneously.
Live imaging of differentiating pancreatic cells at such
high resolution could reveal basic cellular aspects of de-
velopment, permit single-cell analysis of phenotypes not
measurable in fixed sections, and enhance studies of
Neurog3-dependent phenotypes. Here, we present ap-
proaches to studying pancreas development that com-
bine somatic gene alterations, mutant analysis, genetic
complementation or suppression, live cell imaging, and
single-cell analysis to assess the regulation of endocrine
cell morphogenesis and differentiation in the developing
pancreas.
RESEARCH DESIGN AND METHODS
Animals
All animal studies were performed in accordance with
Stanford University Institutional Animal Care and Use
Committee guidelines. Mouse Insulin1 promoter–green
fluorescent protein (GFP) transgenic mice were obtained
from The Jackson Laboratory (33). Neurog3gfp knock-in mice
were a gift from Klaus Kaestner (University of Pennsylvania)
(34). NOD-SCID mice for transplantation experiments
were purchased from The Jackson Laboratory.
The Neurog3-tdTomatomosaic transgenic line expresses
tdTomato with a bovine growth hormone polyadenylation
sequence under the control of a 6.5-kb fragment of the
mouse Neurog3 promoter. No growth hormone coding
sequence is present in the transgene construct. The line
was generated in the Stanford Transgenic Mouse Research
Facility. After construct injection, 23 founders were
obtained and were crossed to CD1 females; two lines
were maintained. The line reported here exhibits mosaic
expression, whereas the transgene reported previously
(35) is expressed in all Neurog3-positive cells. Genotyping
was performed using primers to detect the Tomato coding
sequence.
For growth of human pancreatic tissue in the renal
subcapsular space, NOD-SCID mice were anesthetized
with ketamine/xylazine and tissue was transplanted into
the left renal capsule. Kidneys were harvested after 2 weeks
for histological analysis.
Immunofluorescence and RNA Analysis
Tissue was fixed in 4% paraformaldehyde and embedded
in optimal cutting temperature for cryosectioning. Sections
(10 mm) were prepared for immunofluorescence analysis.
Primary antibodies used are indicated in Table 1. Alexa-
Fluor–conjugated secondary antibodies (Life Technologies
and Jackson Immunoresearch) were used for detection.
RNA was purified from organ cultures using the
standard TRIzol protocol (Invitrogen). cDNA was synthe-
sized using the RetroScript kit (Ambion) and was analyzed
by quantitative PCR with commercially available TaqMan
Table 1—Antibodies used in this study
Antigen and host Source Dilution
Neurog3, rabbit polyclonal Seung Kim
Laboratory
1:500
Insulin, guinea pig polyclonal Sigma 1:500
Glucagon, guinea pig polyclonal Linco 1:500
Chromogranin A, rabbit polyclonal Immunostar 1:500
Mucin, hamster monoclonal Neomarkers 1:250
Carboxypeptidase A1, rabbit
polyclonal Chemicon 1:1,000
Dolichos biflorus agglutinin lectin,
biotinylated
Vector
Laboratories 1:1,000
GFP, chicken polyclonal Abcam 1:500
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probes (Applied Biosystems) for genes indicated in the
text. Analysis of sorted cell populations by FACS was per-
formed as previously described using transgenes indicated
in the text (36). Adenovirally expressed human NEUROG3
was detected using custom TaqMan probes: 6-FAM/
CTGGGAAGGTGGGCAGGACA/TAMRA-Sp (probe), CTC
AACTCGGCACTGGAC (primer), and AGATGTAGTTGTG
GGCGAAG (primer). Expression levels were normalized to
ActB, and results were shown as levels relative to control
samples indicated in the text. At least three independent
organs were analyzed for each condition.
Organ Culture and Imaging
Fetal pancreata were dissected on ice from mice at
embryonic day (E) 13.5 for culture and imaging. Epithe-
lium and mesenchyme from dorsal and ventral remained
visibly intact. Organ rudiments were visually screened
for the expression of Ins1-GFP, Neurog3-tdTomatom, or
Neurog3gfp alleles with a Leica epifluorescence dissect-
ing microscope. Neurog3gfp/gfp organs were distinguished
from Neurog3gfp/+ organs visually by morphology and
GFP intensity. Genotypes were confirmed retrospectively
by PCR for the presence of GFP and the wild-type
Neurog3 allele.
After dissection, organ rudiments were transferred to
a chambered cover slip (Nunc Laboratory-Tek) or a 60-mm
tissue culture dish and embedded in type 1 collagen gel
(Wako). Organs were cultured in phenol red-free DMEM/
F12 (Invitrogen) supplemented with 10% FBS (HyClone),
1% penicillin streptomycin, and 1% insulin/transferrin/
selenium (Sigma). Media was refreshed every 2 days of
culture. Vascular labeling was accomplished by inject-
ing fluorescein isothiocyanate–conjugated Lycopersicum
esculentum lectin (Vector Laboratories) into the umbil-
ical vein of the E13.5 fetus before separation from the
placenta.
Imaging was performed using Zeiss LSM510 and Leica
SP5 confocal microscopes with 320 water-immersion
objectives and environmental-control chambers to main-
tain an imaging environment at 37°C with 5% CO2.
Images were acquired at 1,024 3 1,024 resolution with
4 mm separating Z sections and 20 min separating Z-stack
acquisitions. Data were saved in LSM (Zeiss) or LIF (Leica)
formats. ImageJ (National Institutes of Health) or Voloc-
ity (PerkinElmer) was used to compile Z stacks into XYT
datasets, which were exported in TIFF format for analysis
or AVI and MOV formats for viewing.
Analysis of Imaging Data
Movies were analyzed in ImageJ. For cell shape analysis,
individual cells were manually traced and shape factor was
calculated at each time point using the “Circularity” func-
tion. Shape factor = 4p(area)/(perimeter2). Cell shape
traces over time were manually generated in ImageJ and
analyzed using Microsoft Excel. Shape factor of single
cells was traced from the first time point at which a cell
was clearly detected until the last time point at which it
could be distinguished from other cells. Simple averaging
of single-cell shape traces did not indicate a stereotyped
pattern of deformation for either Neurog3-tdTomato or
Ins1-GFP cells. Normalization to the mean shape factor of
an epithelial cell (E-cadherinhigh pancreatic epithelial cells)
followed by integration of the single-cell shape factor
curve generated a plot of single-cell accumulated shape
factor over time, a measure of a single cell’s accumulated
deviation from epithelioid shape. This path-independent
measure of deformation allowed measurement of cell de-
formation undergone over time by defined cell popula-
tions. For statistical comparisons, area under the curve
was computed for each individual sample, and biological
groups were compared using a t test.
Clustering was analyzed by computing mean object size
at each time point using the “Analyze Particles” function
in ImageJ (32). Clustering values were normalized to the
value calculated at t = 0 and plotted over time. Data were
analyzed in Microsoft Excel.
GFPhigh cells in Neurog3gfp/+, Neurog3gfp/gfp, and Ad-NEU-
ROG3 rescues were counted from Z stacks 50–70 mm
thick acquired at single time points at the beginning of
live imaging data sets. At least three organs per condi-
tion were analyzed.
Human Tissue
Experiments involving use of human tissue were ap-
proved by the Stanford University Institutional Review
Board. Human pancreatic tissue between gestational days
76 and 110 was obtained through the Birth Defects
Research Laboratory, University of Washington (Seattle,
WA), and all donors provided informed consent.
Identification of Human NEUROG3P39X Mutation
The study protocol was approved by the University of
California, Los Angeles, institutional review board, and
pertinent medical history, pathology, and DNA samples
were obtained from the subject. The subject presented
clinically with severe malabsorptive diarrhea as a neonate,
and like others with enteric anendocrinosis was managed
with parenteral nutrition (16). At 3 years of age, diabetes
was diagnosed, and a C-peptide level of 3.6 ng/mL was
measured (M.G.M., unpublished data). An Oragene saliva
kit was used to obtain DNA, and exon 2 of NEUROG3 was
PCR amplified and sequenced using oligonucleotides
(59CAATCGAATGCACGACCTCAAC-39 [sense] and 59-AGAT-
TATGGGGTGGTGGCAGAG-39 [antisense]). Sequencing
revealed a homozygous single base deletion in codon 39
(c.117delC; p.P39PfsX38), leading to a frame-shift mutation
and 38 additional amino acids that are out of frame prior to
a premature transcriptional termination sequence (M.G.M.,
unpublished data).
Adenovirus Construction
Adenoviruses were generated by cloning cDNAs of in-
terest into the pDual-RFP-CCM or pDual-H2B:mCherry
shuttle vectors, which express a fluorescent protein and
the gene of interest under the control of separate cyto-
megalovirus promoters. The pDual-H2B:mCherry vector
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was constructed by amplification of the H2B:mCherry cDNA
sequence by PCR from pcDNA3-H2B:mCherry (Addgene
Plasmid 20972) and replacing the red fluorescent protein
(RFP) sequence in pDual-RFP (Vector Biolabs, Philadel-
phia, PA). Custom high-titer adenoviruses ($1 3 1010
plaque-forming units/mL) were generated by Vector Biol-
abs for all viruses except Ad-NEUROD1 and Ad-PAX6,
which were purchased premade from Vector Biolabs. All
adenovirus work was performed in compliance with reg-
ulations from the Stanford University Administrative
Panel on Biosafety.
Adenovirus Microinjection
Pancreatic rudiments were dissected from E13.5 embryos,
preserving both dorsal and ventral pancreatic epithelia
and mesenchyme. Intact pancreas rudiments were sepa-
rated from surrounding intestinal and vascular structures.
Organs were embedded in Type 1 Collagen gel (see above),
and gel was allowed to polymerize for 1 h at 37°C before
overlaying with cell culture media. Organs were incubated
at 37°C for at least 1 h before beginning the injection
procedure.
For injections, needles were produced by pulling 25 mL
glass microcapillary tubes (no filament, cat. no. 53432-
761; VWR) using a Flaming/Brown micropipette puller
(model P-87; Sutter Instrument Co.) with the following
settings: pressure 400, heat 580, pull 75, velocity 60, time
100. Needles were mounted on a brass straight-arm nee-
dle holder (MINJ-4; Tritech Research) attached to a stan-
dard manual control micromanipulator (640056; Harvard
Apparatus). For preparation of needles, tips were broken
with forceps, and viral solution (1 3 106 plaque-forming
units/mL) was loaded by drawing into the needle through
the tip. A syringe and tubing filled with mineral oil were
used to control pressure for delivery of the injection
solutions.
Cultured pancreatic rudiments were visualized under
a stereomicroscope, and epithelial structures were visually
distinguished from mesenchyme: mesenchyme appears
opaque under reflected light illumination, whereas epi-
thelial structures appear translucent. Less than 2 mL virus
solution was injected into the epithelium: larger volumes
caused distension of the organ and could rupture the
tissue. Efficiency of labeling could be increased by enter-
ing the epithelium at multiple locations throughout the
dorsal and ventral pancreas, but doing so increased the
risk of transducing nonepithelial cells. Injection solution
was delivered slowly to minimize distension of the epi-
thelial network. Viral labeling of pancreatic epithelial cells
occurred in essentially all organs attempted, and epithelial
restriction occurred in .80% of rudiments (n . 100).
Fluorescence from a cytomegalovirus-RFP reporter trans-
gene was detectable by the day after injection and in-
creased through at least 5 days of culture. Addition of
adenovirus only to the organ culture media, without in-
jection, primarily resulted in infection of mesenchymal
cells along the surface of the organ (data not shown).
Statistical Analysis
A two-tailed Student t test was used for statistical com-
parisons of gene expression, cell counts, and live-cell phe-
notypes. P values ,0.05 were considered significant. Data
are presented as means 6 SEM.
RESULTS
Restoration of Islet Development in Neurog3 Mutants
by Targeted Gene Transduction
Assessment of pancreas developmental genetics, espe-
cially transcriptional regulators of epithelial development,
could be advanced by tests of gene function in a de-
velopmentally relevant context. For example, such assays
could permit complementation or suppression analysis.
To achieve this goal, we tested whether Neurog3 mutant
phenotypes could be rescued by exploiting the accessibil-
ity of pancreatic epithelium to microinjection in organ
cultures. We embedded E13.5 organs in collagen gel and
overlaid with culture media (37). Over 5 days of culture,
we observed substantial growth and multilineage differ-
entiation. After identifying the fetal pancreatic duct,
we injected recombinant adenoviral vectors expressing
a transgene encoding RFP (mRFP) into the lumen of cul-
tured Neurog3gfp/gfp pancreatic rudiments (Fig. 1A). The
Neurog3gfp allele replaces the coding sequence of Neurog3
with GFP, creating a null allele (34). The viral injection
solution appeared restricted to the ductal epithelial tree.
Consistent with this, immunostaining of rudiments after
5 days of culture showed that expression of mRFP was
predominantly restricted to pancreatic epithelial cells (Fig.
1B and C). Quantification revealed that 31 6 4% of pan-
creatic E-cadherin+ epithelial cells coexpressed RFP, indi-
cating a high efficiency of infection and gene transduction
(n = 4) (Fig. 1B and C). Thus, genetic transduction of fetal
pancreatic epithelium was feasible in our system.
To assess the capacity for genetic complementation, we
next injected homozygous mutant Neurog3gfp/gfp rudi-
ments with adenovirus coexpressing wild-type human
NEUROG3 and RFP or control virus expressing RFP alone.
Human mouse Neurog3 share 75% identity at the protein
level. At baseline, Neurog3 mutants fail to form islet cells,
express markers of islet differentiation, or form islet-like
cell clusters (5,6), phenotypes recapitulated in our organ
cultures (see below). In addition, GFP expression is very
low in Neurog3gfp/gfp organs relative to Neurog3gfp/+ con-
trols, likely reflecting a lack of positive autoregulation in
Neurog3-null pancreata (38). After transduction with wild-
type NEUROG3, quantitative PCR (qPCR) analysis revealed
that NEUROG3 rescue resulted in a significant restoration
of islet markers, with expression of Neurog3 target genes
comparable with Neurog3gfp/+ controls (Fig. 1D and Sup-
plementary Fig. 1). For example, we observed restored
expression of several direct targets of Neurog3, including
NeuroD1 and Rfx6, as well as expression of genes encoding
islet hormones, including Ins2 and Gcg (Fig. 1D). Expres-
sion levels of Neurog3 target genes approached levels in
Neurog3gfp/+ littermates but did not reach those observed
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Figure 1—Transduction of Neurog3 mutant fetal pancreatic cells with human NEUROG3 by adenovirus microinjection restores islet
differentiation and morphogenesis. A–C: Microinjection of adenovirus into the fetal pancreatic epithelium permits transduction of epithelial
cells. D: Rescue of islet-specific gene expression in Neurog3gfp/gfp organ rudiments by expression of wild-type human NEUROG3 and
assessment of enteric anendocrinosis patient-derived allele function. E: Histological evidence of islet differentiation and morphogenesis.
Ad-NEUROG3 efficiently restores islet gene expression and formation of islet cell clusters. The R107S patient allele restores a limited
amount of differentiation, consistent with hypomorphic function. P39X and N89D (RFP) alleles fail to induce any changes in islet gene
expression or morphogenesis, consistent with complete lack of function. Gene expression measurements were normalized to control
Neurog3gfp/+;Ad-RFP cDNA. *P < 0.05, Student t test.
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in Neurog3+/+ controls, indicating that the level of
NEUROG3 rescue was partial (Supplementary Fig. 1).
Pdx1, a gene expressed independently of Neurog3 in pan-
creatic epithelial progenitors, remained unchanged as
expected. Immunostaining of Neurog3gfp/gfp organs
injected with Ad-NEUROG3 confirmed restoration of in-
sulin and glucagon protein expression and demonstrated
the formation of large endocrine cell clusters resembling
control islets (Fig. 1E). We also observed a marked increase
in GFP intensity, expressed from the endogenous Neurog3
locus, throughout Neurog3gfp/gfp organ rudiments injected
with Ad-NEUROG3 (Fig. 1E) (see below), consistent with
NEUROG3 autoregulatory activity (38). In control
Neurog3gfp/+ organs injected with Ad-RFP, we observed
220 6 27 GFPhigh cells per field, while in Neurog3gfp/gfp;
Ad-RFP control organs we observed only 6 6 1 GFPhigh
cells per field (P = 0.001) (Supplementary Fig. 1). (See
RESEARCH DESIGN AND METHODS.) Thus, infection with virus,
per se, did not induce GFP expression. Expression of wild-
type NEUROG3 restored GFPhigh cell counts to 212 6 17
cells per field in Neurog3gfp/gfp (P = 0.001 relative to
Neurog3gfp/gfp, P = 0.52 relative to Neurog3gfp/+). These find-
ings provide additional unique evidence that NEUROG3 is
capable of positive autoregulation (38). All rescued cells, as
indicated by elevated GFP expression or expression of islet
markers including ChgA, also coexpressed the RFP re-
porter, suggesting that the rescue observed was cell au-
tonomous (Supplementary Fig. 1). In summary, our organ
culture and microinjection system revealed the capacity
for genetic complementation studies in mouse Neurog3
mutant pancreata.
Complementation Analysis of Human NEUROG3
Alleles
Mutations in NEUROG3 have been linked to human con-
genital diarrhea and intestinal anendocrinosis with diabe-
tes of variable onset and severity (14–16). It remains unclear,
however, whether diabetes severity reflects a range of
allele strength because current methods used to test
NEUROG3 alleles rely on in vitro cell line assays or ectopic
expression in prepancreatic endoderm of nonmammalian
model organisms. These systems may not recapitulate the
appropriate pancreatic developmental context and do not
yet permit analysis of dynamic phenotypes regulated by
NEUROG3.
To test the function of three mutant human NEUROG3
alleles in native fetal pancreatic epithelial cells, we micro-
injected adenoviruses into the Neurog3gfp/gfp epithelium
and cultured organs for 5 days, assaying the ability of each
allele to restore endocrine gene expression and features of
islet morphogenesis. We tested the NEUROG3R107S patient
allele (16), the synthetic null mutant NEUROG3N89D (17),
and NEUROG3P39X, a new patient-derived allele (M.G.M.,
unpublished observations). qPCR probes that recognize
wild-type and mutant forms of NEUROG3 revealed com-
parable levels of corresponding transgenic NEUROG3
mRNA after infection (Supplementary Fig. 1). Expression
of NEUROG3R107S restored GFPhigh expression in a signif-
icant fraction of cells (48 6 5 cells per field, P = 0.001
compared with 6 6 1 in Ad-RFP control, Supplementary
Fig. 1). Consistent with this finding, we also observed that
expression of mRNAs encoding pancreatic endocrine factors
and hormones was partially restored by NEUROG3R107S
(Fig. 1D). Hormone production was also detected by im-
munohistology in rudiments rescued by NEUROG3R107S
(Fig. 1E). By contrast, we detected no increase in GFP
fluorescence after delivery of the NEUROG3 P39X allele
compared with Ad-RFP and Ad-N89D negative controls
(7 6 1 vs. 6 6 1 cells per field, P = 0.29 compared with
Ad-RFP control, Supplementary Fig. 1). Together these
data support prior studies suggesting that NEUROG3R107S
is a hypomorphic allele (17) and provide evidence that
NEUROG3P39X is a null allele.
We postulated that our gene transduction system
based on organ culture and subsequent analysis could be
adapted to study human fetal pancreas development.
We developed a sequential strategy for microinjection of
adenoviral vectors into the ductal lumen of human fetal
pancreatic tissue to modify gene expression, followed by
transplantation in NOD-SCID mice to permit vasculariza-
tion and development (39,40). We then tested whether
misexpression of NEUROG3 was sufficient to induce en-
docrine differentiation in developing human pancreatic
tissue. All adenoviruses coexpressed RFP under control
of a second promoter to permit identification of trans-
duced cells. Upon misexpression of wild-type NEUROG3,
we observed clear induction of the “pan-endocrine” marker
protein Chromogranin A (CHGA) within many transduced
cells and establishment of large RFP-expressing cell clus-
ters (Supplementary Fig. 2). CHGA expression was ob-
served in 67 6 2% of cells overexpressing wild-type
NEUROG3. In contrast, we observed CHGA expression
in only 12 6 3% of RFP+ transduced cells in organs in-
fected with the control NEUROG3N89D mutant, which
lacks DNA-binding activity (P = 1.3 3 1024, n = 3) (Sup-
plementary Fig. 2). Thus, NEUROG3 misexpression was
sufficient to direct endocrine differentiation and to pro-
mote islet cell cluster formation in developing human
pancreatic cells.
Genetic Suppression of Neurog3 Mutant Phenotypes
Classical mutant suppression analysis can reveal or clarify
functions of genetic regulators but to our knowledge has
not previously been achieved with pancreas developmen-
tal mutants. Targets of Neurog3 include NeuroD1, Rfx6,
and Pax4 (18,19,22,23). We used adenoviral vectors to
express human orthologs of these factors or the islet
transcriptional regulator PAX6 to assess their ability to
suppress phenotypes in Neurog3gfp/gfp mutant rudiments.
We observed that NEUROD1 overexpression partially
restored expression of mRNA encoding chromogranin A
and islet hormones compared with undetectable expres-
sion in controls infected with Ad-RFP (Fig. 2A). Moreover,
we observed ChgA protein expression by GFPhigh cells in
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small clusters adjacent to major ductal structures (Fig. 2B
and C). Restoration of hormone and ChgA mRNA expres-
sion in these studies indicates successful suppression
or bypass of the Neurog3 mutation, although the magni-
tude of effect was less than that achieved by NEUROG3
complementation. By contrast, genetic suppression of
Neurog3gfp/gfp pancreas development using other transcrip-
tional regulators was less robust. Ad-RFX6 infection led to
a small but significant induction of ChgA (5.7% of control;
P = 0.03) (Fig. 2A) but not other markers of islet develop-
ment. PAX6 significantly induced mRNA encoding glucagon
(P = 2 3 1028) (Supplementary Fig. 3) but not other
markers, consistent with known roles for Pax6 in activating
a-cell–specific gene expression and a-cell differentiation
(41–43). Infection with adenovirus encoding Pax4 resulted
in no detectable changes of mRNA levels relative to Ad-RFP
controls for genes including all islet hormones, Neurod1, and
ChgA (Supplementary Fig. 3). In combination, NEUROD1
and RFX6 induced both ChgA and Ghrelin mRNA to levels
greater than achieved by NEUROD1 alone (Fig. 2A and
Supplementary Fig. 3) (P = 9 3 1024 and P = 0.03, re-
spectively) and generated small multicellular clusters that
expressed ChgA protein. Multiple other factors or combi-
nations did not result in additional restoration of islet
differentiation (Supplementary Fig. 3). Together, these data
suggest that RFX6 and NEUROD1 may collaborate to in-
duce endocrine differentiation and islet cell aggregation
without NEUROG3. Collectively, these results also show
that genetic suppression analysis is feasible in our system.
Two-Color Live Imaging at Single-Cell Resolution
Reveals Cell Movement, Deformation, Differentiation,
and Morphogenesis by Developing Fetal Pancreatic
Cells
Tools to study living islet precursors at single-cell reso-
lution could enhance studies of islet development, in-
cluding assessment of Neurog3 gene functions. To image
and assess distinct live cell types in pancreas develop-
ment, including our genetic complementation studies,
we first labeled endocrine precursor cells by generating
transgenic mice expressing the RFP tdTomato (44) under
the control of a 6.5-kb fragment of the mouse Neurog3
promoter (35). Immunostaining and FACS purification of
pancreatic cells from this Neurog3-tdTomato transgenic
line confirmed tdTomato labeling in fetal Neurog3-
expressing pancreatic cells (Supplementary Fig. 4). Because
of the perdurance of tdTomato labeling, we observed
tdTomato expression in differentiated hormone+ islet cell
progeny of Neurog3-expressing cells (Supplementary Fig. 4).
FACS and immunofluorescence analysis demonstrated
that tdTomato transgene expression was mosaic in the
mouse line used for these studies, labeling approximately
half the Neurog3-expressing pancreatic cells marked by
a Neurog3gfp knock-in allele (34). This level of mosaicism
facilitated subsequent single-cell tracking (see below) and
Figure 2—Suppression of Neurog3gfp/gfp phenotypes by downstream targets of NEUROG3. A: Injection of Neurog3gfp/gfp fetal pancreatic
epithelia with adenoviruses carrying single and combinations of factors partially restores expression of markers of endocrine differentiation.
Expression of NEUROD1 induced small increases in expression of all hormones and of ChgA. Expression of RFX6 alone caused small but
significant increases in ChgA expression. Combination of NEUROD1 and RFX6 induced expression of Ghrelin (see Supplementary Fig. 1)
and ChgA but not expression of other hormones. B–E: Histological analysis of organs injected with factors downstream of NEUROG3
reveals ChgA-expressing cells as singlets or small clusters exiting the pancreatic epithelium in Neurog3gfp/gfp;Ad-NEUROD1 organs and
fails to show any ChgA protein expression in Neurog3gfp/gfp;Ad-RFX6 organs. Organs transduced with RFX6 and NEUROD1 viruses in
combination formed small clusters of ChgA-expressing cells separated from the epithelium. Scale bars: 25 mm. Gene expression measure-
ments were normalized to Neurog3gfp/+;Ad-RFP controls. *P < 0.05, Student t test.
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distinguishes this line from one without mosaicism pre-
viously reported by our group (35). To label both endo-
crine precursors and hormone-expressing b-cells, we bred
Neurog3-tdTomato mice with Insulin1-GFP transgenic mice
(33). Resulting bitransgenic Neurog3-tdTomato;Ins1-GFP
embryos enabled simultaneous labeling and tracking of
Neurog3-expressing endocrine precursors and nascent fe-
tal insulin-expressing b-cells in the same cultured pan-
creas rudiments. Thus, Neurog3-tdTomato transgenic
mice provide a tool for analyzing a subset of living en-
docrine progenitor cells.
Islet cell differentiation and morphogenesis after birth
of Neurog3+ cells requires several days; thus, to permit
imaging experiments of sufficient duration, we next
established a stable system for fetal pancreatic culture,
development, and growth that minimized artifactual tis-
sue movement. We used the same collagen-embedded organ
culture scheme described above for rescue experiments, in
which growth and differentiation occur as assessed by
histology and qPCR (Supplementary Figs. 5 and 6). Immu-
nohistology also revealed islet cell clustering after 5 days
of culture (Supplementary Fig. 6). Thus, multiple criteria
indicated that development of the three major cell line-
ages in the fetal pancreas occurred and that fundamental
features of islet morphogenesis were reproduced in this
culture system. To establish that our frame of reference
for live imaging was stable, we labeled the vasculature by
injecting fluorescein isothiocyanate–conjugated tomato
lectin through the umbilical vein of mice prior to pancreas
extraction; imaging of cells relative to the static vascular
“reference” label indicated that our imaging field was sta-
ble (Supplementary Fig. 5 and Supplementary Movie 1).
To confirm that we analyzed single cells, we labeled nuclei
with a histone H2B:GFP transgene (45) and endocrine
precursors with Neurog3-tdTomato and calculated the
mean two-dimensional area of single cells. We used that
area, 104 6 7 mm2, as a reference during our analysis to
identify single cells for tracking (Supplementary Fig. 5).
A wave of pancreatic endocrine differentiation begins
in fetal mice at approximately E13.5 (1). Thus, we cul-
tured organs isolated at E13.5 and imaged at 20-min time
intervals for 48 h to assess islet cell dynamics. Live imag-
ing revealed several phenotypes in pancreata of Neurog3-
tdTomato;Ins1-GFP mice (Fig. 3A–D and Supplementary
Movie 2). We directly observed differentiation of individ-
ual red Neurog3-tdTomato+ endocrine precursor cells, as
they initiated expression of Ins1-GFP and became progres-
sively yellow and then green (Fig. 3E–H). Not all Neurog3-
tdTomato–expressing cells generated Ins1-GFP–expressing
cells during our time-lapse studies, consistent with prior
studies showing that Neurog3+ cells generate b-cells and
non-b-cells and with immunostaining data indicating that
Tomato+ cells also expressed glucagon or insulin after
organ culture experiments (Supplementary Fig. 6). More-
over, not all Ins1-GFP cells were derived from Neurog3-
tdTomato+ cells, consistent with transgene mosaicism in
this line. Second, we observed movement of Neurog3-
tdTomato+ and Ins1-GFP+ single cells into multicellular
clusters (Fig. 3A–D and Supplementary Movie 2). At the
end of time-lapse imaging, green Ins1-GFP+ multicellular
clusters were a dominant feature. Thus, our studies per-
mitted observation of endocrine differentiation and mul-
ticellular morphogenesis in living tissue at single-cell
resolution. Third, imaging revealed that Neurog3-tdTomato
and Ins1-GFP cells achieved often-dramatic morphological
deformation, involving extension and retraction of cellu-
lar processes resembling filopodia, while moving into mul-
ticellular nascent islets (Fig. 3I–L). For example, in some
Figure 3—Time-lapse confocal microscopy of developing islet cells reveals dynamic single-cell phenotypes. Endocrine precursors at E13.5
were labeled with a mosaic Neurog3-tdTomato transgene, and insulin-expressing cells were labeled with an Insulin1-GFP transgene. Cell
movement and deformation are visible in both populations, and clustering and differentiation of b-cells are observed throughout the movie.
A–D: Frames from a 48-h movie. E–H: Single Neurog3-tdTomato–expressing cells differentiate into b-cells, initiating expression of the
Ins1-GFP transgene. I–L: Extensive cell deformation and extension of processes are observed during cell movement and clustering.
Scale bars: 200 mm (A–D) and 25 mm (E–L).
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cases, cells extended processes up to three times longer
than the cell body diameter (Fig. 3I–L), a degree of de-
formation not previously reported to our knowledge.
Thus, we have developed an organ culture and imaging
system enabling discovery and measurement of dynamic
cellular phenotypes during pancreatic endocrine differen-
tiation and islet development.
Quantitative Analysis of Live-Cell Phenotypes in
Pancreas Development
The single-cell resolution afforded by our live imaging
system permitted quantification of dynamic cellular
phenotypes like shape changes, movement, and clustering
during endocrine differentiation. To quantify cell defor-
mation, we calculated the shape factor of cells, which relates
cell perimeter and area. A shape factor of zero corre-
sponds to a straight line, whereas a shape factor of 1.0
corresponds to a perfect circle (Fig. 4A and B). We found
that the mean shape factor of a fetal pancreatic ductal
epithelial cell after immunostaining with an E-cadherin
antibody (see RESEARCH DESIGN AND METHODS) was 0.83 6
0.01 (Supplementary Fig. 6). Prior studies have applied
shape factor measurements to analyze cell shape in islet
development but relied on single or instantaneous mea-
surements, which may obscure dynamic single-cell pheno-
types over time (46,47). We took advantage of our ability
to track single cells over many hours of development and
integrated the accumulated deformation of a cell over
time. Tracking the shape factor of single cells during
our time-lapse studies yielded continuous single-cell shape
traces (Fig. 4A and B, green line). We normalized to epi-
thelial shape, integrated shape factor curves with respect
to time, and calculated the accumulated deviation from
epithelioid shape of individual Neurog3-tdTomato+ cells and
motile Ins1-GFP+ cells not yet merged with islets (Fig. 4A
and B, blue line). We observed no significant difference
in the shape factor between Neurog3-tdTomato+ and Ins1-GFP+
cells (P = 0.61) (Fig. 4C). This similarity of cumulative cell
shape changes is therefore consistent with our observa-
tion that differentiating pancreatic endocrine cells begin
Figure 4—Quantitative analysis of dynamic cell phenotypes. Single-cell resolution live cell imaging enables quantification of phenotypes
including deformation and clustering. Shape factor, a measure of deformation, was calculated over time for a single b-cell (A) and a single
Neurog3-tdTomato endocrine precursor (B). A shape factor value of one corresponds to a perfect circle, and a value of zero corresponds to
a straight line. Integration of the single-cell shape factor curve (green lines in A and B) with respect to time provides the single-cell
accumulated shape factor (scASF), a path-independent measurement corresponding to the amount of deformation undergone by a single
cell (blue lines in A and B). C: Calculation of mean accumulated shape factors for the Neurog3-tdTomato and Ins1-GFP cell populations
demonstrates no quantitative difference in deformation as observed by time-lapse microscopy. D: Calculation of the clustering index for the
two cell populations indicates that the Ins1-GFP population tends to cluster more than the Neurog3-tdTomato population. Hrs, hours.
diabetes.diabetesjournals.org Pauerstein and Associates 3045
deformation and movement at the Neurog3-expressing
stage and maintain those phenotypes during the initial
stages of Ins2 expression in moving b-cells.
To quantify Neurog3-tdTomato+ and Ins1-GFP+ cell
clustering in nascent islets, we adapted a clustering index
previously used to assess pancreatic cell aggregation (32).
This measurement calculates “object” size in image data:
thus, assuming consistent cell size, increased object size
corresponds to increased clustering of fetal islet cells. We
normalized the clustering index to its value at t = 0 h for
each time-lapse study to facilitate statistical comparisons
of changes in clustering across multiple movies. We ob-
served a transient decrease in the clustering index of
Neurog3-tdTomato+ cells, consistent with the observation
that these cells originate from fetal pancreatic epithelium
and disperse during migration toward islet cell clusters
(Fig. 4D). By contrast, Ins1-GFP+ cell aggregation was re-
flected by a large increase in their clustering index (P = 0.03)
(Fig. 4D). These live-cell measurements should be useful for
describing experimental alterations in islet cell migratory
patterns and clustering, including the analysis of pheno-
types in mutant pancreatic development (see below).
Neurog3 Is Required for Cell Shape Changes and
Migration Into Nascent Islet Clusters
Prior studies suggest that Neurog3 is required for the
mobilization of islet progenitors from fetal epithelium,
although the evidence for this has been indirectly inferred
from fixed tissue analyses (9,26). For example, lineage
tracing of Neurog3-null cells suggests that these cells re-
main within the fetal pancreatic epithelium, where they
redirect their fate toward ductal or acinar cell lineages
(13,48). To test directly the requirement for Neurog3
in islet cell deformation and movement, we imaged
Neurog3gfp/gfp organs at E13.5. In heterozygote controls,
imaging revealed highly dynamic Neurog3gfp/+ cells that
deformed and extended processes, moved, and eventually
clustered in nascent islets (Fig. 5A–C and Supplementary
Movie 3). By contrast, homozygous Neurog3gfp/gfp cells
failed to initiate movement and remained in epithelial
tubes (Fig. 5D–F and Supplementary Movie 4). Quan-
tification of the shape factor for homozygous mutant
Neurog3gfp/gfp cells revealed a significant reduction in cell
deformation compared with control Neurog3gfp/+ cells
(P = 0.006) (Fig. 5G). The lack of cell aggregation or islet
differentiation in Neurog3gfp/gfp organs precluded quanti-
fication of clustering. Thus, single-cell imaging methods
identified defects in pancreatic cell migration in mice lack-
ing Neurog3.
To test whether rescue of Neurog3 mutant phenotypes
by human NEUROG3 alleles extended to live-cell defor-
mation phenotypes, we generated time-lapse movies of
Neurog3gfp/gfp organ rudiments injected with adenoviruses
expressing human NEUROG3 alleles. In contrast to Ad-
RFP or Ad-NEUROG3N89D injection, Ad-NEUROG3 in
Neurog3gfp/gfp organs restored cell movement, shape changes,
and islet morphogenesis. Any GFPhigh cells detected in
Neurog3gfp/gfp;Ad-NEUROG3R107S organs also underwent
deformation, suggesting a binary output in which cells
with high Neurog3 activity undergo deformation, whereas
cells with low Neurog3 activity do not (Fig. 5H–K and
Supplementary Movies 5–7). Consistent with the lack of
activity detected for NEUROG3P39X, we did not detect
GFPhigh cells or cell deformation in Neurog3gfp/gfp;Ad-
NEUROG3P39X organs (Fig. 5J and Supplementary Movie
8). Together with molecular and immunohistological data
above, these data provide evidence for rescue of multiple
dynamic phenotypes by functional human NEUROG3 alleles.
DISCUSSION
Detailed assessment of cell and developmental pheno-
types in normal and mutant living tissue provides power-
ful opportunities to understand gene function in
organogenesis. Here, we describe a combination of fetal
organ culture, live imaging, and genetic methods to
dissect functions of Neurog3, a gene crucial for endocrine
cell ontogeny and islet morphogenesis in the pancreas. By
creating platforms for unique gene complementation and
suppression studies in Neurog3mutant tissue, we evaluated
the function of human disease-associated Neurog3 muta-
tions and assessed the capacity for Neurog3-independent
islet differentiation. Quantification of dynamic cell phe-
notypes in distinct endocrine progeny with single-cell res-
olution in the fetal pancreas permitted us to measure and
show that Neurog3 is required for initiating multiple steps
in islet morphogenesis, including cell deformation, move-
ment, differentiation into hormone-expressing progeny,
and cell aggregation to form nascent islets. The dissection
of gene functions and cell dynamics using approaches de-
tailed here should accelerate discovery of cell and genetic
mechanisms underlying the mechanisms that coordinate
islet formation.
Development of methods for transgenic alterations in
cultured pancreatic tissue developing ex vivo permitted us
to efficiently assess the capacity for patient-derived
human alleles of NEUROG3 to induce islet differentiation
and formation. In these studies, we were able to study the
activity of these alleles in a developmentally relevant con-
text in pancreatic cells at an embryonic stage appropriate
for Neurog3 expression. Prior assessments of activity of
these alleles has relied on in vitro assays in cell lines that
are not known to have capacity for islet differentiation or
on assays using chick embryonic models of endodermal
development in Neurog3 wild-type backgrounds (14–17).
In these other systems, autoregulation by endogenous
Neurog3 could complicate interpretation of results. By
using embryonic Neurog3-null mouse pancreatic tissue
and assessing multiple Neurog3-dependent phenotypes—
including autoregulation, morphological changes, and ac-
tivation of islet gene expression programs—we provide
unique evidence that while at least one NEUROG3 allele
associated with enteric anendocrinosis is hypomorphic,
the newly identified NEUROG3P39X allele has no detect-
able function and is likely a null allele.
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The proband homozygous for the NEUROG3P39X allele
did not develop neonatal insulin-dependent diabetes and
had detectable serum C-peptide, suggesting b-cell devel-
opment and function in this patient (M.G.M., unpublished
observations). Thus, to the extent that NEUROG3P39X is
a null allele, our studies raise the possibility that NEUROG3
function may not be required for b-cell development to
the same degree as in mice, a possibility consistent with
prior human studies (14,15). In some vertebrates, includ-
ing pigs and zebrafish, a clear ortholog of NEUROG3 has
not been identified. Thus, we speculate that other tran-
scription factors could substitute for Neurog3 in regulating
islet cell development in human islet development, as is the
case for Ascl1b and Neurod1 in zebrafish (49). Consistent
with this possibility, here we observed that NEUROD1
overexpression was sufficient for partial bypass of the
requirement for Neurog3 in mouse islet development in
cultured fetal pancreata. Establishment of NEUROG3P39X
as a null allele suggests that a NEUROG3-independent
gene network may permit formation of a limited popula-
tion of islet cells in human development.
The gene delivery methods described here should en-
able testing of genetic hypotheses using gain-of-function
methods, including dissection of pathways regulating islet
differentiation downstream of Neurog3. For example, de-
livery of direct Neurog3 target genes including NeuroD1
was sufficient to restore some islet differentiation in
Neurog3-null pancreas. Without using in vitro gene deliv-
ery methods, similar genetic suppression experiments
might require generation of multiple new mouse trans-
genic or knock-in lines. In addition, we demonstrate that
similar viral methods could be applied to analyze human
pancreatic development, enabling future studies relevant
to human biology. We recognize limitations to viral
Figure 5—Time-lapse imaging of cells lacking Neurog3 reveals a failure to undergo morphological changes and cell migration. A–C: Cells
heterozygous for Neurog3gfp migrate and cluster, whereas Neurog3gfp/gfp cells (D–F) fail to leave epithelial tubules. G: A significant
quantitative reduction in cell deformation was detected. H–K: Evaluation of the capacity for human NEUROG3 alleles to induce islet cell
deformation. Wild-type NEUROG3 restores cell deformation and movement, NEUROG3R107S has a limited capacity for rescue and restores
motility in only a few scattered cells, and NEUROG3P39X and NEUROG3N89D have no detectable effect on islet cell movement phenotypes.
Scale bars: 100 mm. P value from Student t test.
diabetes.diabetesjournals.org Pauerstein and Associates 3047
expression of transgenes, which may include failure to ap-
propriately regulate transcript levels and background label-
ing of nonepithelial cell types. In principle, these
approaches permitting genetic complementation should be
readily adaptable to study the activity of other genes and
alleles in pancreas development or any other fetal organ
accessible to in vitro culture and viral gene transduction.
Dual-color confocal imaging permitted assessment of
transient or dynamic phenotypes like cell deformation and
movement across multiple stages of islet development.
Compared with prior efforts at live cell analysis (32,47,50),
we present data using single cells from multiple cell pop-
ulations tracked simultaneously. These studies demon-
strate the capacity for directly observing differentiation
and tracking morphological dynamics of single cells. The
cell shape changes and cellular extensions observed in our
video data were not detected in fixed sections, possibly
reflecting limitations of histological approaches to preserve
fine or transient subcellular morphologies (51). Applying
quantitative methods, we described the maintenance of
migratory phenotypes as islet cells differentiate from
hormone-negative endocrine precursors into hormone-
expressing fetal b-cells. Thus, our work provides a founda-
tion for analysis of disrupted islet cell development and
morphogenesis in mutant pancreatic development.
To develop methods for genetic studies of living tissue,
we analyzed Neurog3 mutants—which have severe disrup-
tions of cell movement and clustering—and optimized
methods for quantifying and analyzing these phenotypes.
Although indirect evidence suggested that Neurog3 con-
trols the acquisition of cell deformation or migratory phe-
notypes (9,48), here we have provided direct evidence for
a failure by islet progenitor cells to initiate cell shape
changes or movement in the absence of Neurog3. Future
experiments could dissect whether acquisition of migra-
tory phenotypes is invariably linked to islet differentia-
tion or whether one process could occur in the absence of
the other. We also applied live-imaging methods to visu-
alize directly the failure of pancreatic cells to elevate
Neurog3 promoter activity in Neurog3 knockout cells, cor-
roborating prior findings supporting a positive autoregu-
latory loop driving fetal pancreatic Neurog3 expression
(38). Consistent with the results from our genetic com-
plementation experiments, we found that NEUROG3
alleles could restore morphogenetic movements, with
the number of motile cells observed in each organ rudi-
ment proportional to allele strength. Overall, the imaging
methods we have developed could allow tracking of
the behavior of multiple cell populations in the context
of genetic or chemical interventions in pancreatic
development.
In summary, we have assessed human allele function in
a developmentally relevant context, evaluated the capacity
for Neurog3 targets to restore islet differentiation in the
absence of Neurog3, and measured live cell phenotypes in
normal and mutant islet development. The methods de-
scribed here should be useful for dissecting genetic
networks and cell biological events controlling pancreatic
islet development.
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